|
James S. Kuo MD MBA is the Chairman and Chief Executive Officer of Duska Therapeutics Inc. a public biopharmaceutical company. Dr. Kuo has been a founder Chairman and Chief Executive Officer of BioMicro Systems Inc. a private venture-backed microfluidics company. Prior to that time Dr. Kuo was a founder President and Chief Executive Officer of Discovery Laboratories Inc. where he raised over $22 million in initial private funding and took the company public. He further has been a founder and a Board Director of Monarch Labs LLC a private medical device company.
Dr. Kuo is the former Managing Director of Venture Analysis for HealthCare Ventures LLC which managed $378 million in venture funds. He has also been a senior licensing and business development executive at Pfizer Inc. where he was directly responsible for cardiovascular licensing and development.
After studying molecular biology and receiving his B.A. at Haverford College Dr. Kuo simultaneously received his M.D. from The University of Pennsylvania School of Medicine and his MBA from The Wharton School of Business at the University of Pennsylvania. | 